Safety Profile of a Novel γ-Aminobutyric Acid Type B Receptor (GABA B ) Agonist, Lesogaberan, as an Add-on to Proton Pump Inhibitor (PPI) Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients Who Have a Partial Response to PPI Therapy
2012 ◽
Vol 47
(7)
◽
pp. 751-761
◽
2016 ◽
Vol 22
(3)
◽
pp. 355-366
◽
2019 ◽
Vol 103
(1)
◽
pp. 15-27
◽